Traveler's Diarrhea Archives

Bausch Health Files Lawsuit Against Sandoz

Bausch Health Companies Inc., together with wholly owned subsidiary Salix Pharmaceuticals Inc.’s licensor Alfasigma SpA, announced the filing of a lawsuit against Sandoz Inc. alleging patent infringement of 14 patents by the Novartis division’s submission of an Abbreviated New Drug Application for Xifaxan

(rifaximin) 550 mg tablets.

October 1, 2019/by PR Newswire

FDA Approves Aemcolo For Travelers’ Diarrhea

Antibiotics, Approvals, Bacteria, Clinical Data, E. Coli, FDA, FDA/Regulatory, Traveler's Diarrhea

The U.S. FDA approved Aries Pharmaceuticals Inc.’s Aemcolo (rifamycin) for the treatment of adult patients with Travelers’ Diarrhea caused by non-invasive strains of Escherichia coli.

November 19, 2018/by PR Newswire